Stay updated on BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.

Latest updates to the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page
- Check5 days agoChange DetectedRemoved the 'Multiple Myeloma' condition label and the 'MedlinePlus Genetics' related topics from the study page.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded related topics for the study: Multiple myeloma and MedlinePlus Genetics.SummaryDifference0.2%

- Check27 days agoChange DetectedRevision: v3.5.0 added. The page no longer includes 'Multiple myeloma' or 'MedlinePlus Genetics' as related topics in the related topics section.SummaryDifference0.2%

- Check41 days agoChange DetectedMetadata and taxonomy updates were applied to the study page, including new date entries and related topic references (Multiple myeloma and MedlinePlus Genetics). The revision tag was updated from v3.4.2 to v3.4.3, and older revision entries were removed.SummaryDifference0.6%

- Check49 days agoChange DetectedRemoved references to Multiple Myeloma and MedlinePlus Genetics from the page.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No study content or user-facing features were altered.SummaryDifference0.1%

Stay in the know with updates to BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.